Medicare Enrolled
Dr. James Barry, M.D.
Neurology · Bedford, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Barry from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Barry?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Barry
Dr. James Barry is a neurology specialist in Bedford, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Barry performed 103,430 Medicare services across 2,069 unique beneficiaries.
Between the years covered by Open Payments, Dr. Barry received a total of $116,251 from 102 pharmaceutical and/or device companies across 2059 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Barry is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in TX
$116,251 industry payments
Medicare Practice Summary
Medicare Utilization ↗103,430
Medicare services
Top 0% in TX for neurology
2,069
Unique beneficiaries
$25
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~5,172 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 37,302 | $38 | $139 |
| Injection, natalizumab, 1 mg | 32,400 | $14 | $27 |
| Denosumab injection (Prolia/Xgeva) | 14,580 | $19 | $30 |
| Ocrelizumab infusion (Ocrevus) for MS | 10,200 | $20 | $53 |
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,020 | $4 | $9 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
809 | $90 | $195 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
745 | $16 | $110 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
436 | $49 | $180 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
322 | $11 | $40 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
296 | $4 | $9 |
| Anti-nausea injection (ondansetron/Zofran) | 225 | $0 | $2 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
151 | $111 | $260 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
116 | $134 | $400 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
116 | $59 | $145 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
110 | $6 | $130 |
| Complete ultrasound of brain blood flow An ultrasound test that evaluates blood flow within the brain's blood vessels. It uses sound waves to create images of the vessels and assess circulation. |
105 | $214 | $525 |
| EEG, extended monitoring A test that records electrical activity in the brain while the patient is both awake and asleep. |
102 | $343 | $650 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
83 | $12 | $37 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
54 | $29 | $85 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
43 | $96 | $260 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
43 | $22 | $60 |
| Electromyography of arm or leg muscles A test that measures the electrical activity in the muscles of the arm or leg using a needle electrode. It helps evaluate the health of muscles and the nerve cells that control them. |
35 | $75 | $150 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
28 | $24 | $85 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
24 | $53 | $137 |
| Nerve conduction study, 9-10 studies A diagnostic test that measures how well nerves send electrical signals. It involves performing 9 to 10 separate nerve conduction studies to evaluate nerve function. |
21 | $161 | $375 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
19 | $100 | $360 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $124 | $245 |
| New patient office visit, complex (60-74 min) | 15 | $164 | $300 |
| Visual evoked potential test A test that measures how quickly electrical signals travel from the eye to the brain in response to visual stimuli. |
14 | $45 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.0% high complexity
87.8% medium
1.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$116,251
Total received (2018-2024)
Avg $16,607/year across 7 years
Top 5% in TX for neurology
102
Companies
2,059
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$80,977 (69.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$28,475 (24.5%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$6,798 (5.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$4,693
2023
$5,036
2022
$12,599
2021
$14,837
2020
$11,219
2019
$37,819
2018
$30,047
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Biogen, Inc.
$31,852
GENZYME CORPORATION
$26,174
Genentech USA, Inc.
$18,173
Celgene Corporation
$7,152
Teva Pharmaceuticals USA, Inc.
$4,802
Banner Life Sciences, LLC
$3,512
Novartis Pharmaceuticals Corporation
$2,248
Grifols USA, LLC
$1,366
EMD Serono, Inc.
$1,286
Amgen Inc.
$1,194
ABBVIE INC.
$1,177
ACADIA Pharmaceuticals Inc
$1,170
UCB, Inc.
$1,169
AbbVie Inc.
$898
Alexion Pharmaceuticals, Inc.
$858
CSL Behring
$608
Allergan, Inc.
$557
Allergan Inc.
$531
Lilly USA, LLC
$518
SK Life Science, Inc.
$462
Alnylam Pharmaceuticals Inc.
$432
Merz Pharmaceuticals, LLC
$399
PFIZER INC.
$391
Neurocrine Biosciences, Inc.
$384
Acorda Therapeutics, Inc
$363
Amneal Pharmaceuticals LLC
$360
Lundbeck LLC
$359
Horizon Therapeutics plc
$336
Sunovion Pharmaceuticals Inc.
$319
Biohaven Pharmaceutical Holding Company Ltd.
$308
Janssen Pharmaceuticals, Inc
$297
Supernus Pharmaceuticals, Inc.
$289
JAZZ PHARMACEUTICALS INC.
$265
Biohaven Pharmaceuticals, Inc.
$264
IMPEL PHARMACEUTICALS INC.
$237
ARGENX US, INC.
$230
TG THERAPEUTICS, INC.
$227
MITSUBISHI TANABE PHARMA AMERICA, INC.
$223
Kyowa Kirin, Inc.
$211
Ipsen Biopharmaceuticals, Inc
$200
AbbVie, Inc.
$182
US WorldMeds, LLC
$179
Scilex Pharmaceuticals Inc.
$171
Adamas Pharmaceuticals, Inc.
$170
GE HEALTHCARE
$158
Octapharma USA, Inc.
$157
Eisai Inc.
$152
Boston Scientific Corporation
$147
Harmony Biosciences LLC
$145
E.R. Squibb & Sons, L.L.C.
$140
TG Therapeutics, Inc.
$132
MDD US Operations, LLC
$128
Mallinckrodt Enterprises LLC
$127
Exeltis, USA Inc.
$119
Merz North America, Inc.
$117
UPSHER-SMITH LABORATORIES LLC
$116
Avanir Pharmaceuticals, Inc.
$116
Upsher-Smith Laboratories LLC
$115
REVANCE THERAPEUTICS, INC.
$100
ARBOR PHARMACEUTICALS, INC.
$98
MERZ NORTH AMERICA, INC.
$88
GE HealthCare
$84
Takeda Pharmaceuticals U.S.A., Inc.
$82
Amylyx Pharmaceuticals, Inc.
$81
Mitsubishi Tanabe Pharma America, Inc.
$79
Jazz Pharmaceuticals Inc.
$79
Genentech, Inc.
$76
Mallinckrodt Hospital Products Inc.
$75
BOSTON SCIENTIFIC CORPORATION
$73
ANI Pharmaceuticals, Inc.
$71
Assertio Therapeutics, Inc.
$56
Bausch Health US, LLC
$56
CATALYST PHARMACEUTICALS, INC.
$50
BANNER LIFE SCIENCES, LLC
$49
Promius Pharma LLC
$49
Axsome Therapeutics, Inc.
$39
Sumitomo Pharma America, Inc.
$37
Otsuka America Pharmaceutical, Inc.
$33
Aprecia Pharmaceuticals, LLC
$33
Nevro Corp.
$33
LivaNova USA, Inc.
$32
Avion Pharmaceuticals
$31
AstraZeneca Pharmaceuticals LP
$30
Mallinckrodt LLC
$29
Azurity Pharmaceuticals, Inc.
$28
Arbor Pharmaceuticals, Inc.
$25
Currax Pharmaceuticals LLC
$25
Greenwich Biosciences, Inc.
$24
GE Healthcare
$23
Vanda Pharmaceuticals Inc.
$21
Collegium Pharmaceutical, Inc.
$20
Stryker Corporation
$20
Almatica Pharma LLC
$17
Ultragenyx Pharmaceutical Inc.
$17
Vertical Pharmaceuticals, LLC
$16
Sandoz Inc.
$16
Impax Laboratories, Inc.
$16
Mylan Pharmaceuticals Inc.
$16
Abbott Laboratories
$14
IDORSIA PHARMACEUTICALS US INC
$14
HARMONY BIOSCIENCES LLC
$14
Philips Electronics North America Corporation
$12
Top 3 companies account for 65.5% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · APOKYN · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX - SPASTICITY · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Briviact · CAMBIA · CONTRAVE · COPAXONE · CREXONT · DAXXIFY · DUOPA · DYSPORT · Dhivy · Duopa · Dysport · ELYXYB - celecoxib · EMGALITY · EPIDIOLEX · EVENITY · Epidiolex · Evrysdi · FABRY-DISEASE · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL DBS · GENERAL DBS · GILENYA · GOCOVRI · GamaSTAN · Gamunex-C · Glatiramer Acetate · Gocovri · Gralise · HORIZANT · Hizentra · Horizant · INBRIJA · INGREZZA · KESIMPTA · KISUNLA · KYNMOBI · LEMTRADA · LEQEMBI · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · MYOBLOC · Mavenclad · NAPRELAN · NEXVIAZYME · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Nourianz · Nuedexta · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONFI · ONGENTYS · ONGENTYS 50MG CAPSULES 30 · ONPATTRO · ONZETRA XSAIL · OSMOLEX ER · Ocrevus · Ocrevus Zunovo · Ongentys · Ozanimod · PANZYGA · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · Privigen · Proclaim Family of SCS IPGs · QALSODY · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RADICAVA · RELYVRIO · RYTARY · Radicava · Rebif · Rituxan · Rystiggo · SOLIRIS · SPINRAZA · SUNOSI · Senza · Soliris · Spritam · Sunosi · TARGET · TECFIDERA · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VERCISE · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VNS Therapy · VUMERITY · VYALEV · VYEPTI · VYVGART · VYVGART HYTRULO · Vercise · Vimpat · WAKIX · WATCHMAN · Wakix · Wellcentive Undiv · XEOMIN · XYREM · XYWAV · Xadago · Xembify · Xeomin · Xyrem · ZEMBRACE SYMTOUCH · ZEPOSIA · ZIPSOR · ZTLido · Zembrace · Zembrace SymTouch Sumatriptan Injection · Zinbryta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (70%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in TX.
Equivalent to $112 per 100 Medicare services performed
Geographic Context
Neurologists within 10 mi
249
Per 100K population
11.7
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HURST-EULESS-BEDFORD
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Barry is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with speaking/promotional industry engagement in the top 5% of TX peers, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Barry experienced with injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg?
Based on Medicare claims data, Dr. Barry performed 37,302 injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Barry receive payments from pharmaceutical companies?
Yes. Dr. Barry received a total of $116,251 from 102 companies across 2,059 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Barry's costs compare to other neurologists in Bedford?
Dr. Barry's average Medicare payment per service is $25. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Barry) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Bedford
Browse neurologists in Bedford ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in TX
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in TX
Which TX neurologists receive the most from drug and device companies.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
By company
GENZYME CORPORATION Payments to Doctors
See all physicians who received payments from GENZYME CORPORATION.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology